Syngene Strengthens Leadership Team with Key Appointments

IMT News Desk
IMT News Desk
· 2 min read
Syngene International appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO

Syngene International has announced the appointment of Maninder Kapoor Puri as Chief Human Resources Officer (CHRO) and Abhijit Zutshi as Chief Commercial Officer (CCO), effective May 1, 2026. These strategic hires bolster the company’s executive committee amid its push for global growth in research, development, and manufacturing services.

Maninder Kapoor Puri brings nearly three decades of global HR leadership, driving business performance through people strategies, leadership development, culture, and digital HR ecosystems. Her expertise spans biopharmaceuticals, IT services, and consulting across North America, EMEA, and APAC. She has partnered with CEOs and boards on large-scale, multi-market transformations to build high-performance organizations.

Most recently, as CHRO at Biocon, Puri led enterprise-wide culture and leadership transformations. Previously, she served as Global CHRO at Mastek, overseeing HR across 40+ countries, with leadership roles at Accenture and Firstsource Solutions. Recognized by Outlook Business as a face of “Viksit Bharat,” she ranks among HR Today’s Top 100 Global CHROs, India’s Most Agile Leaders (2026), and CHRO of the Year.

As Syngene’s CHRO and Executive Committee member, Puri will spearhead the global people agenda to fuel the company’s next growth phase.

Abhijit (Abhi) Zutshi joins as Chief Commercial Officer, based in the United States. As an Executive Committee member, he will drive Syngene’s commercial operations, including sales, client partnerships, marketing, brand building, digital initiatives, and account management.

Zutshi offers 27 years of pharmaceutical commercial experience across global markets. He spent 25 years at Biocon, most recently as CCO of the generics business, leading drug substance and product divisions while building a global team for generic formulations. His skills cover sales, marketing, business development, portfolio management, and market entry for small and large molecules. Earlier, he led the India launch of Pfizer’s Zosyn brand as a product specialist. Zutshi holds a pharmacy degree, an MBA, and is a Harvard Business School Leadership Development Program graduate.

Peter Bains, Managing Director and CEO of Syngene International, commented: “We are pleased to welcome Maninder and Abhijit to Syngene’s leadership team. Their depth of experience and strong track record in their respective domains will be instrumental as we continue to evolve our service offerings and enhance our value proposition for clients worldwide. These appointments reinforce our commitment to building a world-class leadership team capable of driving our next phase of sustainable growth.”

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk